Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 5/2007

01-05-2007 | Editorial

Is a methodology available that accurately measures the cost of an FDG-PET study?

Authors: Bruno Krug, Anne Sophie Pirson, Ralph Crott, Thierry Vander Borght

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 5/2007

Login to get access

Excerpt

Health care expenses are escalating in many countries. With more restrictive reimbursement schemes based on case-mix funding systems, increasing complexity and rising costs, the health care sector faces a new challenge in becoming more cost efficient. In nuclear medicine, as in other specialties, the rapid growth and development of medical technology has contributed significantly to the steady increase in the costs of medical care. Hospital administrators and governments are being forced to take difficult decisions regarding which new developments in nuclear medicine should be supported financially, e.g. construction of a cyclotron facility, acquisition of new hybrid devices (SPECT/CT and PET/CT) or building of shielded rooms for metabolic therapies [1, 2]. …
Literature
1.
Blackmore CC, Smith WJ. Economic analyses of radiological procedures: a methodological evaluation of the medical literature. Eur J Radiol 1998;27:123–30.CrossRefPubMed
2.
Gambhir SS. Economics of nuclear medicine. Introduction. Q J Nucl Med 2000;44:103–4.PubMed
3.
Oostenbrink JB, Koopmanschap MA, Rutten FF. Standardisation of costs: the Dutch Manual for Costing in economic evaluations. Pharmacoeconomics 2002;20:443–54.CrossRefPubMed
4.
Drummond M, O’Brien B, Stoddart G. Methods for the economic evaluation of health care programs.New York: Oxford University Press;1997.
5.
Nisenbaum HL, Birnbaum BA, Myers MM, Grossman RI, Gefter WB, Langlotz CP. The costs of CT procedures in an academic radiology department determined by an activity-based costing (ABC) method. J Comput Assist Tomogr 2000;24:813–23.CrossRefPubMed
6.
Chuck A, Jacobs P, Logus JW, St Hilaire D, Chmielowiec C, McEwan AJ. Marginal cost of operating a positron emission tomography center in a regulatory environment. Int J Technol Assess Health Care 2005;21:442–51.CrossRefPubMed
7.
Monge P. The importance of activity-based methods in radiology and the technology that now makes this possible. Radiol Manage 2006;28:52–5.PubMed
8.
Baker J. Activity-based costing and activity-based management for health care. Gaithersburg, MD: Aspen; 1998.
9.
Canby JB 4th. Applying activity-based costing to healthcare settings. Healthc Financ Manage 1995;49:50–52, 54–6.
10.
Gabram SG, Mendola RA, Rozenfeld J, Gamelli RL. Why activity-based costing works. Physician Exec 1997;23:31–7.PubMed
11.
Kaplan RS, Anderson SR. Time-driven activity-based costing. Harv Bus Rev 2004;82:131–8, 150.PubMed
12.
Cohen MD, Hawes DR, Hutchins GD, McPhee WD, LaMasters MB, Fallon RP. Activity-based cost analysis: a method of analyzing the financial and operating performance of academic radiology departments. Radiology 2000;215:708–16.CrossRefPubMed
13.
Player S. Activity-based analyses lead to better decision making. Healthc Financ Manage 1998;52:66–70.PubMed
14.
Aird B. Activity-based cost management in health care—another fad? Int J Health Care Qual Assur 1996;9:16–9.CrossRefPubMed
15.
Adam T, Koopmanschap MA, Evans DB. Cost-effectiveness analysis: can we reduce variability in costing methods? Int J Technol Assess Health Care 2003;19:407–20.CrossRefPubMed
16.
Negrini D, Kettle A, Sheppard L, Mills GH, Edbrooke DL. The cost of a hospital ward in Europe: is there a methodology available to accurately measure the costs? J Health Organ Manag 2004;18:195–206.CrossRefPubMed
Metadata
Title
Is a methodology available that accurately measures the cost of an FDG-PET study?
Authors
Bruno Krug
Anne Sophie Pirson
Ralph Crott
Thierry Vander Borght
Publication date
01-05-2007
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 5/2007
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-006-0308-y

Other articles of this Issue 5/2007

European Journal of Nuclear Medicine and Molecular Imaging 5/2007 Go to the issue

Book review

International Atomic Energy Agency: Nuclear medicine resources manual. 2006. IAEA, Vienna, 532 pp., 55 illustrations. €65.00. ISBN 92-0-107504-9.

Original article

The incremental value of 18F-FDG PET/CT in paediatric malignancies

Original Article

Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate

Molecular Imaging

FDG small animal PET permits early detection of malignant cells in a xenograft murine model

Original Article

1-[11C]-acetate PET imaging in head and neck cancer—a comparison with 18F-FDG-PET: implications for staging and radiotherapy planning

Society communications

Society communications